<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">World J Surg Oncol</journal-id>
      <journal-id journal-id-type="iso-abbrev">World J Surg Oncol</journal-id>
      <journal-title-group>
        <journal-title>World Journal of Surgical Oncology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1477-7819</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24438319</article-id>
      <article-id pub-id-type="pmc">3901337</article-id>
      <article-id pub-id-type="publisher-id">1477-7819-12-17</article-id>
      <article-id pub-id-type="doi">10.1186/1477-7819-12-17</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Response of an aggressive periosteal aneurysmal bone cyst (ABC) of the radius to denosumab therapy</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" id="A1">
          <name>
            <surname>Pauli</surname>
            <given-names>Chantal</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>chantal.pauli@usz.ch</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Fuchs</surname>
            <given-names>Bruno</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>bruno.fuchs@balgrist.ch</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Pfirrmann</surname>
            <given-names>Christian</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>christian.pfirrmann@balgrist.ch</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Bridge</surname>
            <given-names>Julia A</given-names>
          </name>
          <xref ref-type="aff" rid="I4">4</xref>
          <email>jbridge@unmc.edu</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>Hofer</surname>
            <given-names>Silvia</given-names>
          </name>
          <xref ref-type="aff" rid="I5">5</xref>
          <email>silvia.hofer@usz.ch</email>
        </contrib>
        <contrib contrib-type="author" corresp="yes" id="A6">
          <name>
            <surname>Bode</surname>
            <given-names>Beata</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>beata.bode@usz.ch</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Institute of Surgical Pathology, University Hospital Zurich, CH-8091, Zurich, Switzerland</aff>
      <aff id="I2"><label>2</label>Orthopedics, University Hospital Balgrist, Zurich, Switzerland</aff>
      <aff id="I3"><label>3</label>Radiology, University Hospital Balgrist, Zurich, Switzerland</aff>
      <aff id="I4"><label>4</label>Department of Pathology/Microbiology, University of Nebraska Medical Center, Omaha, NE, USA</aff>
      <aff id="I5"><label>5</label>Oncology, University Hospital Zurich, Zurich, Switzerland</aff>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>20</day>
        <month>1</month>
        <year>2014</year>
      </pub-date>
      <volume>12</volume>
      <fpage>17</fpage>
      <lpage>17</lpage>
      <history>
        <date date-type="received">
          <day>23</day>
          <month>8</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>1</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2014 Pauli et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2014</copyright-year>
        <copyright-holder>Pauli et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.wjso.com/content/12/1/17"/>
      <abstract>
        <p>Aneurysmal bone cyst (ABC), once considered a reactive lesion, has been proven to be a neoplasia characterized by rearrangements of the <italic>USP6</italic>-gene. Aggressive local growth and recurrences are common and therapeutic options may be limited due to the vicinity of crucial structures. We describe a case of a locally aggressive, multinucleated giant cell-containing lesion of the forearm of a 21-year old woman, treated with denosumab for recurrent, surgically uncontrollable disease. Under the influence of this RANKL inhibitor, the tumor showed a marked reduction of the content of the osteoclastic giant cells and an extensive metaplastic osteoid production leading to the bony containment, mostly located intracortically in the proximal radius. The diagnosis of a periosteal ABC was confirmed by FISH demonstrating <italic>USP6</italic> gene rearrangement on the initial biopsy. Function conserving surgery could be performed, enabling reconstruction of the affected bone. Inhibition of RANKL with denosumab may offer therapeutic option for patients not only with giant cell tumors but also with ABCs.</p>
      </abstract>
      <kwd-group>
        <kwd>Aneurysmal bone cyst</kwd>
        <kwd>FISH</kwd>
        <kwd>USP6</kwd>
        <kwd>Denosumab</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Aneurysmal bone cysts (ABCs) are rare benign skeletal tumors usually occurring in the first two decades of life and typically associated with a growing mass, swelling, pain and bone destruction
[<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. Approximately 70% of the cases are considered primary lesions and the remaining 30% arising secondary to different primary tumors such as osteoblastoma, giant cell tumor of bone, chondroblastoma, fibrous dysplasia or low grade intramedullary osteosarcoma
[<xref ref-type="bibr" rid="B3">3</xref>]. It has been shown that primary ABCs, initially considered to be reactive and non-neoplastic
[<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>], correspond to a neoplastic disorder associated with a specific set of genetic aberrations
[<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. Over the past few years many different translocations have been described in ABCs, all resulting in oncogenic activation of the <italic>USP6</italic> gene localized to 17p13
[<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B9">9</xref>].</p>
      <p>Primary ABCs can affect any bone. Usually they arise in the metaphysis of long bones such as the femur, tibia and humerus; however, the spine may also be affected with compression/infiltration of nerves and spinal cord causing neurological symptoms
[<xref ref-type="bibr" rid="B10">10</xref>]. The magnetic resonance imaging (MRI) demonstrates an intraosseous, expansile, lytic, eccentric, septated lesion, containing characteristic fluid-fluid levels, except for rare solid ABC variants. Rarely, the ABC is localized on the surface of the long bones
[<xref ref-type="bibr" rid="B11">11</xref>]. Histopathologically, the lesions are composed of hemorrhagic tissue with cavitary spaces separated by fibrous septa composed of spindle cells, inflammatory cells and a smaller percentage of giant cells
[<xref ref-type="bibr" rid="B12">12</xref>]. Treatment options are intralesional curettage followed by bone grafting, in combination with cryotherapy, sclerotherapy, radionuclide ablation, arterial embolization and <italic>en bloc</italic> resection
[<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>]. Complications associated with curettage are related to an incomplete resectability of the lesion resulting in recurrence in at least 20%
[<xref ref-type="bibr" rid="B2">2</xref>]. Clinically
[<xref ref-type="bibr" rid="B15">15</xref>], ABCs can be divided into inactive, active and aggressive lesions with aggressive tumors expanding rapidly, destroying surrounding tissue and having a high rate of local recurrences. New therapeutic options are needed for the management of this locally aggressive disease.</p>
      <p>Denosumab, a monoclonal antibody specifically binding RANK-ligand, inhibits bone resorption and, therefore,
[<xref ref-type="bibr" rid="B16">16</xref>-<xref ref-type="bibr" rid="B18">18</xref>] is used in the treatment of osteoporosis, skeletal complications of metastatic disease, and more recently in the treatment of giant cell tumors of bone, with a high rate of clinical success
[<xref ref-type="bibr" rid="B19">19</xref>]. To date, we are aware of only one publication presenting the application of denosumab in two cases of spinal ABCs
[<xref ref-type="bibr" rid="B20">20</xref>]. Both patients (an 8-year old boy and an 11-year old boy) recovered significantly from pain and neurological symptoms. MRI follow-up after two to four months of denosumab therapy showed tumor regression in both patients. We report a case of a locally aggressive periosteal ABC with a confirmed rearrangement of <italic>USP6</italic> arising in the radius of a 21-year old woman with an impressive local response to denosumab treatment and a follow-up of four years.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>A 21-year old right-handed woman presented with a variable swelling and shooting pain in her right proximal forearm in May of 2009. Clinical examination showed a palpable swelling over the radial head mainly located over the biceps tendon and a supination deficiency. MRI revealed an extensive, deep seated, solid soft tissue tumor with contrast uptake, infiltration of the intra-osseous membranes, biceps tendon, contact with the neurovascular bundle, infiltration of the supinator muscle and deep extensor as well as deep flexor muscles (Figure&#xA0;
<xref ref-type="fig" rid="F1">1</xref>A, B). Computer tomography (CT)-guided core-needle biopsy was performed with a clinical suspicion of Ewing sarcoma. A low-grade, giant cell-containing lesion with focal metaplastic bone formation and infiltration of the skeletal muscle was diagnosed on histopathological examination (Figure&#xA0;
<xref ref-type="fig" rid="F2">2</xref>A). No necrosis, atypia or pathologic mitotic activity was noted. The osteoclastic giant cells were numerous and contained up to over 50 nuclei.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p><bold>Imaging of the patients right forearm tumor. (A)</bold> Initial magnetic resonance imaging (MRI) demonstrating extensive involvement of the soft tissue between the radius and ulna as well as the cortex of the radius by an exclusively solid tumor mass (arrows). <bold>(B)</bold> Pre-treatment computer tomography (CT) scan with a small area of a split and disrupted cortex of the radius (arrows). <bold>(C)</bold> MRI directly prior to denosumab therapy with a locally progressive, extensive soft tissue mass following local surgical therapy 18 months previously. Fluid-fluid levels may be seen at this point (arrow). <bold>(D)</bold> CT scan following five months of denosumab therapy demonstrating almost complete containment of the soft tissue mass by a boney rim (arrow).</p>
        </caption>
        <graphic xlink:href="1477-7819-12-17-1"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p><bold>Histopathology of the pre- and post-treatment tumor tissue specimen. (A)</bold> Pre-treatment biopsy sample showing giant cell containing soft tissue mass with extensive infiltration of the skeletal muscle (H&amp;E stain; original magnification 50&#xD7;). <bold>(B)</bold> Abundant lesional giant cells with numerous nuclei and mononuclear cells in the background (H&amp;E stain; original magnification 100&#xD7;). Inset shows immunohistochemical expression of RANK (dilution 1:400; R&amp;D Systems, Abingdon, United Kingdom) by the osteoclastic giant cells. <bold>(C)</bold> Denosumab treatment induced boney containment (asterisk) of the tumor (upper left) (H&amp;E stain; original magnification 25&#xD7;). <bold>(D)</bold> Post-denosumab-treatment tumor specimen showing pronounced reduction of the number of giant cells (H&amp;E stain; original magnification 100&#xD7;).</p>
        </caption>
        <graphic xlink:href="1477-7819-12-17-2"/>
      </fig>
      <p>Surgical therapy two months later consisted of a curettage through an antero-lateral and dorsal incision with dissection of the radial nerve branches to preserve maximal function. Histology of the recovered fragmented tumor revealed similar results to the biopsy (Figure&#xA0;
<xref ref-type="fig" rid="F2">2</xref>B) rendering the diagnosis of an incompletely resected giant cell tumor of soft tissue. Residual tumor has been followed clinically and on imaging with a new local progression noticed at the end of 2010. MRI in February 2011 (Figure&#xA0;
<xref ref-type="fig" rid="F1">1</xref>C) showed a significant increase in the size of a recurrent and progressively symptomatic tumor. Under the assumption of the diagnosis of a giant cell tumor of soft tissue, the therapy with denosumab (120 mg subcutaneously injected every month) for four months was administered with no untoward side effects. Follow-up MRI after one month of denosumab showed obvious tumor regression in size. Five months after the first denosumab injection, surgery was performed (July 2011). As a result of good treatment response, the tumor had become significantly better circumscribed and clearly demarcated by a bony rim (Figure&#xA0;
<xref ref-type="fig" rid="F1">1</xref>D), leading to the feasibility of a complete resection of the tumor. Reconstruction was performed using an intercalary fibula-allograft with 3D planning to adjust for radial head rotation and a custom-made plate (Figure&#xA0;
<xref ref-type="fig" rid="F3">3</xref>A). The gross examination of the resection specimen (Figure&#xA0;
<xref ref-type="fig" rid="F3">3</xref>B) revealed an extensive, almost circumferential, intracortical bone tumor mass extending over 4.4 cm of the diaphysis of the radius with a small intramedullary nodule proximally and an intracortical satellite lesion distally. The histology of the post-treatment tumor specimen (Figure&#xA0;
<xref ref-type="fig" rid="F2">2</xref>C, D) differed in comparison to the material of the core biopsy and curettage (Figure&#xA0;
<xref ref-type="fig" rid="F2">2</xref>A, B) showing markedly reduced numbers of osteoclasts. The individual giant cells contained only few nuclei. Few small, pseudocystic spaces were observed in the background of collagen rich connective tissue, containing bland mononuclear cells. There was pronounced metaplastic new bone production with extensive areas of so-called &#x2018;blue bone&#x2019; and lamellar cortical bone at the periphery of the lesion (asterisk Figure&#xA0;
<xref ref-type="fig" rid="F2">2</xref>C). Due to the gross findings with almost exclusive intracortical tumor location, the lesion was re-classified as a predominantly intracortical, aneurysmal bone cyst of the proximal radius. Bone and soft tissue resection margins were free of tumor except for an unclear area at the distal corticalis.</p>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p><bold>Resection of the shaft of the proximal radius following the denosumab therapy. (A)</bold> Reconstruction using an intercalary fibula-allograft and a custom-made plate. <bold>(B)</bold> Longitudinal section of the resected specimen demonstrating large intracortical, fully contained by a rim of bone tumor mass (asterisk) with a small intramedullar tumor nodule proximally (black arrow) and an intracortical satellite distally (white arrow).</p>
        </caption>
        <graphic xlink:href="1477-7819-12-17-3"/>
      </fig>
      <p>At first presentation in 2009, most of the exclusively solid tumor mass was localized in the soft tissues of the forearm on imaging (Figure&#xA0;
<xref ref-type="fig" rid="F1">1</xref>A), leading to the diagnosis of giant tumor of soft tissue. Retrospectively, careful analysis of the initial CT scans (Figure&#xA0;
<xref ref-type="fig" rid="F1">1</xref>B) showed an area of split and disrupted cortical bone of the radius, which might have initially suggested the diagnosis of an intracortical (solid variant) ABC with a massive extension to the periosteal tissue. Finally, the diagnosis of a primary ABC was definitively confirmed by demonstration of a rearrangement of the <italic>USP6</italic> gene locus by fluorescence <italic>in situ</italic> hybridization (FISH) as described previously
[<xref ref-type="bibr" rid="B21">21</xref>], utilizing a custom-designed break apart probe set on the original biopsy sample (Figure&#xA0;
<xref ref-type="fig" rid="F4">4</xref>). The mononuclear nuclei exhibit one fused red/green signal corresponding to a normal 17p <italic>USP6</italic> locus (black arrow) and a pair of split green and red signals (white arrows) indicating a rearrangement of the <italic>USP6</italic> locus consistent with the diagnosis of aneurysmal bone cyst.</p>
      <fig id="F4" position="float">
        <label>Figure 4</label>
        <caption>
          <p><bold>Fluorescence </bold><bold><italic>in situ </italic></bold><bold>hybridization conducted on the pretreatment specimen with a custom-designed break apart probe set; the probe cocktail proximal to the </bold><bold><italic>USP6 </italic></bold><bold>locus is labeled in green and distal in red.</bold> The mononuclear nuclei exhibit one fused red/green signal corresponding to a normal 17p <italic>USP6</italic> locus (black arrow) and a pair of split green and red signals (white arrows) indicating a rearrangement of the <italic>USP6</italic> locus consistent with the diagnosis of aneurysmal bone cyst.</p>
        </caption>
        <graphic xlink:href="1477-7819-12-17-4"/>
      </fig>
      <p>Further follow up was unremarkable for another 19 months until a control MRI in February 2013 revealed a small (&lt; 1 cm) lesion in the area of the distal osteotomy and the core biopsy confirmed the local recurrence of the ABC, which is currently being treated with denosumab.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusion</title>
      <p>In this report, we describe a patient treated with denosumab for a locally aggressive, presumed giant cell tumor of soft tissue of the forearm. Evaluation of the resection specimen led to the final diagnosis of an intracortical aneurysmal bone cyst with massive infiltration of the soft tissue, a diagnosis which was also confirmed by FISH analysis.</p>
      <p>Histopathologic differential diagnosis of osteoclastic giant cell containing lesions of skeletal tissues is extensive (giant cell tumor of bone, giant cell tumor of soft tissue, tenosynovial giant cell tumor, aneurysmal bone cyst, reparative giant cell granuloma, brown tumor of hyperparathyroidism, non-ossifying fibroma) and the final diagnosis has to be made in close conjunction with clinical and radiological information. Giant cells occurring in both giant cell tumors (GCTs) and in ABCs are positive for markers of true osteoclasts, expressing RANK (receptor activator of NF-&#x3BA;B) and promoting bone destruction
[<xref ref-type="bibr" rid="B22">22</xref>]. The formation of osteoclast type of giant cells in the GCTs is considered to be a consequence of the local production of RANKL (RANK-ligand) by the mononuclear, true neoplastic tumor cells
[<xref ref-type="bibr" rid="B23">23</xref>]. A current therapeutic option for patients with giant cell tumors of bone is curettage with optimal preservation of function. However, patients undergoing curettage often have recurrent disease or significant morbidity. Denosumab is a human anti-RANKL monoclonal antibody that inhibits RANKL function and therefore its osteoclast activity, and causes the repression of osteoclast recruitment, maturation and bone resorption
[<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B18">18</xref>]. Denosumab is a Food and Drug Administration (FDA)-approved drug for osteoporosis and skeletal-related events in patients with bone metastases. A study to explore the action of denosumab in the treatment of giant cell tumor of bone was performed
[<xref ref-type="bibr" rid="B19">19</xref>], demonstrating that the denosumab treated patients had a decrease in giant cells of 90 percent or greater, an indicator for the reduction of the aggressiveness of the tumors. The application of denosumab for bone tumors other than GCT has rarely been investigated. There exists only one report of denosumab use for ABC in two patients with spinal tumors
[<xref ref-type="bibr" rid="B20">20</xref>]. However, the molecular confirmation of the primary ABCs as well as the histologic changes observed during and following therapy has not been previously reported.</p>
      <p>Denosumab therapy was well tolerated by the current patient. The impressive positive treatment effects on the tumor tissue, as illustrated by marked reduction in the number of giant cells, were coupled with the bony demarcation of the tumor and facilitated subsequent function preserving surgery. The application of this form of the RANKL inhibition led to the transition of a locally aggressive and destructive tumor into a resectable lesion, thus preserving full function in our patient.</p>
      <p>Our observations support the hypothesis that not only patients with GCTs, but also those suffering from ABCs may benefit substantially from RANKL-inhibiting denosumab treatment. These findings may offer new therapeutic options for often young patients with these locally aggressive tumors, especially in uncontrollable, locally destructive or recurrent disease.</p>
    </sec>
    <sec>
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for the publication of this report and any accompanying images.</p>
    </sec>
    <sec>
      <title>Abbreviations</title>
      <p>ABC: Aneurysmal bone cyst; CT: Computer tomography; FISH: Fluorescence <italic>in situ</italic> hybridization; GCT: Giant cell tumor; H&amp;E: Hematoxylin and eosin; MRI: Magnetic resonance imaging; RANK: Receptor activator of NF-&#x3BA;; RANKL: Receptor activator of NF-&#x3BA; ligand; USP6: Ubiquitin carboxyl-terminal hydrolase 6.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors indicate no potential conflict of interests.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; contributions</title>
      <p>CP and BB performed histopathologicals studies and drafted the manuscript. BF and SH coordinated the management and the treatment of the patient, concerning the surgeries and denosumab treatment respectively. CP coordinated the imaging studies. JB carried out the molecular genetic studies. All authors read and approved the final manuscript.</p>
    </sec>
  </body>
  <back>
    <sec>
      <title>Acknowledgments</title>
      <p>The authors would like to thank Dr. Yuanyuan Zhang at UNMC for her technical contributions.</p>
    </sec>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Campanacci</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Cervellati</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Donati</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Bertoni</surname>
            <given-names>F</given-names>
          </name>
          <article-title>Aneurysmal bone cyst (a study of 127 cases, 72 with long term follow up)</article-title>
          <source>Ital J Orthop Traumatol</source>
          <year>1976</year>
          <volume>2</volume>
          <fpage>341</fpage>
          <lpage>353</lpage>
          <pub-id pub-id-type="pmid">1031412</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Mankin</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>Hornicek</surname>
            <given-names>FJ</given-names>
          </name>
          <name>
            <surname>Ortiz-Cruz</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Villafuerte</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Gebhardt</surname>
            <given-names>MC</given-names>
          </name>
          <article-title>Aneurysmal bone cyst: a review of 150 patients</article-title>
          <source>J Clin Oncol</source>
          <year>2005</year>
          <volume>23</volume>
          <fpage>6756</fpage>
          <lpage>6762</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2005.15.255</pub-id>
          <pub-id pub-id-type="pmid">16170183</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cottalorda</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kohler</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Sales de Gauzy</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chotel</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Mazda</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Lefort</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Louahem</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Bourelle</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Dimeglio</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Epidemiology of aneurysmal bone cyst in children: a multicenter study and literature review</article-title>
          <source>J Pediatr Orthop B</source>
          <year>2004</year>
          <volume>13</volume>
          <fpage>389</fpage>
          <lpage>394</lpage>
          <pub-id pub-id-type="doi">10.1097/01202412-200411000-00008</pub-id>
          <pub-id pub-id-type="pmid">15599231</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lichtenstein</surname>
            <given-names>L</given-names>
          </name>
          <article-title>Aneurysmal bone cyst; further observations</article-title>
          <source>Cancer</source>
          <year>1953</year>
          <volume>6</volume>
          <fpage>1228</fpage>
          <lpage>1237</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(195311)6:6&lt;1228::AID-CNCR2820060617&gt;3.0.CO;2-A</pub-id>
          <pub-id pub-id-type="pmid">13106840</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Oliveira</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Hsi</surname>
            <given-names>BL</given-names>
          </name>
          <name>
            <surname>Weremowicz</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rosenberg</surname>
            <given-names>AE</given-names>
          </name>
          <name>
            <surname>Dal Cin</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Joseph</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Bridge</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Perez-Atayde</surname>
            <given-names>AR</given-names>
          </name>
          <name>
            <surname>Fletcher</surname>
            <given-names>JA</given-names>
          </name>
          <article-title>USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst</article-title>
          <source>Cancer Res</source>
          <year>2004</year>
          <volume>64</volume>
          <fpage>1920</fpage>
          <lpage>1923</lpage>
          <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-03-2827</pub-id>
          <pub-id pub-id-type="pmid">15026324</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Oliveira</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Perez-Atayde</surname>
            <given-names>AR</given-names>
          </name>
          <name>
            <surname>Inwards</surname>
            <given-names>CY</given-names>
          </name>
          <name>
            <surname>Medeiros</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Derr</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Hsi</surname>
            <given-names>BL</given-names>
          </name>
          <name>
            <surname>Gebhardt</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Rosenberg</surname>
            <given-names>AE</given-names>
          </name>
          <name>
            <surname>Fletcher</surname>
            <given-names>JA</given-names>
          </name>
          <article-title>USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts</article-title>
          <source>Am J Pathol</source>
          <year>2004</year>
          <volume>165</volume>
          <fpage>1773</fpage>
          <lpage>1780</lpage>
          <pub-id pub-id-type="doi">10.1016/S0002-9440(10)63432-3</pub-id>
          <pub-id pub-id-type="pmid">15509545</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lau</surname>
            <given-names>AW</given-names>
          </name>
          <name>
            <surname>Pringle</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Quick</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Riquelme</surname>
            <given-names>DN</given-names>
          </name>
          <name>
            <surname>Ye</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Oliveira</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Chou</surname>
            <given-names>MM</given-names>
          </name>
          <article-title>TRE17/ubiquitin-specific protease 6 (USP6) oncogene translocated in aneurysmal bone cyst blocks osteoblastic maturation via an autocrine mechanism involving bone morphogenetic protein dysregulation</article-title>
          <source>J Biol Chem</source>
          <year>2010</year>
          <volume>285</volume>
          <fpage>37111</fpage>
          <lpage>37120</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M110.175133</pub-id>
          <pub-id pub-id-type="pmid">20864534</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Oliveira</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Chou</surname>
            <given-names>MM</given-names>
          </name>
          <name>
            <surname>Perez-Atayde</surname>
            <given-names>AR</given-names>
          </name>
          <name>
            <surname>Rosenberg</surname>
            <given-names>AE</given-names>
          </name>
          <article-title>Aneurysmal bone cyst: a neoplasm driven by upregulation of the USP6 oncogene</article-title>
          <source>J Clin Oncol</source>
          <year>2006</year>
          <volume>24</volume>
          <fpage>e1</fpage>
          <comment>author reply e2</comment>
          <pub-id pub-id-type="doi">10.1200/JCO.2005.04.4818</pub-id>
          <pub-id pub-id-type="pmid">16382110</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ye</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Pringle</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Lau</surname>
            <given-names>AW</given-names>
          </name>
          <name>
            <surname>Riquelme</surname>
            <given-names>DN</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Lev</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Welman</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Blobel</surname>
            <given-names>GA</given-names>
          </name>
          <name>
            <surname>Oliveira</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Chou</surname>
            <given-names>MM</given-names>
          </name>
          <article-title>TRE17/USP6 oncogene translocated in aneurysmal bone cyst induces matrix metalloproteinase production via activation of NF-kappaB</article-title>
          <source>Oncogene</source>
          <year>2010</year>
          <volume>29</volume>
          <fpage>3619</fpage>
          <lpage>3629</lpage>
          <pub-id pub-id-type="doi">10.1038/onc.2010.116</pub-id>
          <pub-id pub-id-type="pmid">20418905</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Nielsen</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Fletcher</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Soft tissue aneurysmal bone cyst: a clinicopathologic study of five cases</article-title>
          <source>Am J Surg Pathol</source>
          <year>2002</year>
          <volume>26</volume>
          <fpage>64</fpage>
          <lpage>69</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-200201000-00007</pub-id>
          <pub-id pub-id-type="pmid">11756770</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Maiya</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Davies</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Evans</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Grimer</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Surface aneurysmal bone cysts: a pictorial review</article-title>
          <source>Eur Radiol</source>
          <year>2002</year>
          <volume>12</volume>
          <fpage>99</fpage>
          <lpage>108</lpage>
          <pub-id pub-id-type="doi">10.1007/s003300101009</pub-id>
          <pub-id pub-id-type="pmid">11868083</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Dabska</surname>
            <given-names>MBJ</given-names>
          </name>
          <article-title>Aneurysmal bone cyst: pathology, clinical course and radiologic appearances</article-title>
          <source>Cancer</source>
          <year>1969</year>
          <volume>23</volume>
          <fpage>371</fpage>
          <lpage>389</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(196902)23:2&lt;371::AID-CNCR2820230213&gt;3.0.CO;2-2</pub-id>
          <pub-id pub-id-type="pmid">5764977</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Garg</surname>
            <given-names>SMS</given-names>
          </name>
          <name>
            <surname>Dormans</surname>
            <given-names>JP</given-names>
          </name>
          <article-title>Modern surgical treatment of primary aneurysmal bone cyst of the spine in children and adolescents</article-title>
          <source>J Pediatr Orthop</source>
          <year>2005</year>
          <volume>25</volume>
          <fpage>387</fpage>
          <lpage>392</lpage>
          <pub-id pub-id-type="doi">10.1097/01.bpo.0000152910.16045.ee</pub-id>
          <pub-id pub-id-type="pmid">15832161</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Peeters</surname>
            <given-names>SP</given-names>
          </name>
          <name>
            <surname>Van der Geest</surname>
            <given-names>IC</given-names>
          </name>
          <name>
            <surname>de Rooy</surname>
            <given-names>JW</given-names>
          </name>
          <name>
            <surname>Veth</surname>
            <given-names>RP</given-names>
          </name>
          <name>
            <surname>Schreuder</surname>
            <given-names>HW</given-names>
          </name>
          <article-title>Aneurysmal bone cyst: the role of cryosurgery as local adjuvant treatment</article-title>
          <source>J Surg Oncol</source>
          <year>2009</year>
          <volume>100</volume>
          <fpage>719</fpage>
          <lpage>724</lpage>
          <pub-id pub-id-type="doi">10.1002/jso.21410</pub-id>
          <pub-id pub-id-type="pmid">19821494</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Enneking</surname>
            <given-names>WF</given-names>
          </name>
          <article-title>A system of staging musculoskeletal neoplasms</article-title>
          <source>Clin Orthop Relat Res</source>
          <year>1986</year>
          <volume>204</volume>
          <fpage>9</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="pmid">3456859</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hanley</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Adachi</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Bell</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>V</given-names>
          </name>
          <article-title>Denosumab: mechanism of action and clinical outcomes</article-title>
          <source>Int J Clin Pract</source>
          <year>2012</year>
          <volume>66</volume>
          <fpage>1139</fpage>
          <lpage>1146</lpage>
          <pub-id pub-id-type="doi">10.1111/ijcp.12022</pub-id>
          <pub-id pub-id-type="pmid">22967310</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lipton</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Jacobs</surname>
            <given-names>I</given-names>
          </name>
          <article-title>Denosumab: benefits of RANK ligand inhibition in cancer patients</article-title>
          <source>Curr Opin Support Palliat Care</source>
          <year>2011</year>
          <volume>5</volume>
          <fpage>258</fpage>
          <lpage>264</lpage>
          <pub-id pub-id-type="doi">10.1097/SPC.0b013e328349731c</pub-id>
          <pub-id pub-id-type="pmid">21826000</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Moen</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Keam</surname>
            <given-names>SJ</given-names>
          </name>
          <article-title>Denosumab: a review of its use in the treatment of postmenopausal osteoporosis</article-title>
          <source>Drugs Aging</source>
          <year>2011</year>
          <volume>28</volume>
          <fpage>63</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="doi">10.2165/11203300-000000000-00000</pub-id>
          <pub-id pub-id-type="pmid">21174488</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Thomas</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Henshaw</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Skubitz</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Chawla</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Staddon</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Blay</surname>
            <given-names>J-Y</given-names>
          </name>
          <name>
            <surname>Roudier</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ye</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Sohn</surname>
            <given-names>W</given-names>
          </name>
          <etal/>
          <article-title>Denosumab in patients with giant-cell tumor of bone: an open-label, phase 2 study</article-title>
          <source>Lancet Oncol</source>
          <year>2010</year>
          <volume>11</volume>
          <fpage>275</fpage>
          <lpage>280</lpage>
          <pub-id pub-id-type="doi">10.1016/S1470-2045(10)70010-3</pub-id>
          <pub-id pub-id-type="pmid">20149736</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lange</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Stehling</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Frohlich</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Klingenhofer</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kunkel</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Schneppenheim</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Escherich</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Gosheger</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Hardes</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Jurgens</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Schulte</surname>
            <given-names>TL</given-names>
          </name>
          <article-title>Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts</article-title>
          <source>Eur Spine J</source>
          <year>2013</year>
          <volume>22</volume>
          <fpage>1417</fpage>
          <lpage>1422</lpage>
          <pub-id pub-id-type="doi">10.1007/s00586-013-2715-7</pub-id>
          <pub-id pub-id-type="pmid">23455951</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Althof</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Ohmori</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bailey</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Bridge</surname>
            <given-names>RS</given-names>
          </name>
          <name>
            <surname>Nelson</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Neff</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Bridge</surname>
            <given-names>JA</given-names>
          </name>
          <article-title>Cytogenetic and molecular cytogenetic findings in 43 aneurysmal bone cysts: aberrations of 17p mapped to 17p13.2 by fluorescence <italic>in situ</italic> hybridization</article-title>
          <source>Mod Pathol</source>
          <year>2004</year>
          <volume>17</volume>
          <fpage>518</fpage>
          <lpage>525</lpage>
          <pub-id pub-id-type="doi">10.1038/modpathol.3800090</pub-id>
          <pub-id pub-id-type="pmid">15044915</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Won</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kalil</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>Y-K</given-names>
          </name>
          <article-title>RANK signaling in bone lesions with osteoclast-like giant cells</article-title>
          <source>Pathology</source>
          <year>2011</year>
          <volume>43</volume>
          <fpage>318</fpage>
          <lpage>321</lpage>
          <pub-id pub-id-type="doi">10.1097/PAT.0b013e3283463536</pub-id>
          <pub-id pub-id-type="pmid">21532526</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Thomas</surname>
            <given-names>D</given-names>
          </name>
          <article-title>RANKL, denosumab, and giant cell tumor of bone</article-title>
          <source>Curr Opin Oncol</source>
          <year>2012</year>
          <volume>24</volume>
          <fpage>397</fpage>
          <lpage>403</lpage>
          <pub-id pub-id-type="doi">10.1097/CCO.0b013e328354c129</pub-id>
          <pub-id pub-id-type="pmid">22581354</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
